A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 radar

European Urology

Volumn 65, Issue 5, 2014, Pages 856-864

  Galvão, Daniel A ^a   Spry, Nigel ^a,b,c   Denham, James ^d,e   Taaffe, Dennis R ^a,f   Cormie, Prue ^a   Joseph, David ^a,b,c   Lamb, David S ^g   Chambers, Suzanne K ^a,h,i   Newton, Robert U ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e NEWCASTLE MATER HOSPITAL   (Australia)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g UNIVERSITY OF OTAGO   (New Zealand)

^h GRIFFITH UNIVERSITY   (Australia)

ⁱ VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

Author keywords

Androgen deprivation; Musculoskeletal system; Physical exercise; Physical function; Quality of life; Resistance training

Indexed keywords

BIOLOGICAL MARKER;

AEROBIC EXERCISE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BACKACHE; BODY COMPOSITION; BODY WEIGHT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FITNESS; HEART INFARCTION; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

ANDROGEN DEPRIVATION; MUSCULOSKELETAL SYSTEM; PHYSICAL EXERCISE; PHYSICAL FUNCTION; QUALITY OF LIFE; RESISTANCE TRAINING;

AGED; ANDROGEN ANTAGONISTS; BLOOD PRESSURE; BODY COMPOSITION; CHOLESTEROL, HDL; EXERCISE THERAPY; HUMANS; LEG; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PATIENT EDUCATION AS TOPIC; PHYSICAL CONDITIONING, HUMAN; PHYSICAL FITNESS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SELF REPORT; TIME FACTORS; TORSO;

EID: 84896389387     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.09.041     Document Type: Article

References (29)

1. M. Braga-Basaria, A.S. Dobs, and D.C. Muller et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy J Clin Oncol 24 2006 3979 3983
2. M.R. Smith, H. Lee, and D.M. Nathan Insulin sensitivity during combined androgen blockade for prostate cancer J Clin Endocrinol Metab 91 2006 1305 1308
3. D.A. Galvão, N.A. Spry, and D.R. Taaffe et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer BJU Int 102 2008 44 47
4. D.A. Galvão, D.R. Taaffe, N. Spry, D. Joseph, D. Turner, and R.U. Newton Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation Prostate Cancer Prostatic Dis 12 2009 198 203
5. G.W. Bong, H.S. Clarke Jr., W.C. Hancock, and T.E. Keane Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer Urology 71 2008 1177 1180
6. H. Kaku, T. Saika, and T. Tsushima et al. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer Prostate 66 2006 439 444
7. M. Wei, J.B. Kampert, and C.E. Barlow et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men JAMA 282 1999 1547 1553
8. R.S. Paffenbarger Jr., R.T. Hyde, A.L. Wing, I.M. Lee, D.L. Jung, and J.B. Kampert The association of changes in physical-activity level and other lifestyle characteristics with mortality among men N Engl J Med 328 1993 538 545
9. D.A. Galvão, R.U. Newton, D.R. Taaffe, and N. Spry Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT? Nat Clin Pract Urol 5 2008 306 307
10. M.C. Morey, D.C. Snyder, and R. Sloane et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial JAMA 301 2009 1883 1891
11. D.A. Galvão, D.R. Taaffe, N. Spry, D. Joseph, and R.U. Newton Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial J Clin Oncol 28 2010 340 347
12. D.A. Galvão, D.R. Taaffe, N. Spry, D. Joseph, and R.U. Newton Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response J Urol 186 2011 1291 1297
13. R.J. Segal, R.D. Reid, and K.S. Courneya et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer J Clin Oncol 21 2003 1653 1659
14. R.J. Segal, R.D. Reid, and K.S. Courneya et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer J Clin Oncol 27 2009 344 351
15. K.H. Schmitz, K.S. Courneya, and C. Matthews et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors Med Sci Sports Exerc 42 2010 1409 1426
16. J.W. Denham, C. Wilcox, and D. Joseph et al. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial Lancet Oncol 13 2012 1260 1270
17. D.A. Galvão, and R.U. Newton Review of exercise intervention studies in cancer patients J Clin Oncol 23 2005 899 909
18. G. Godin, and R.J. Shephard A simple method to assess exercise behavior in the community Can J Appl Sport Sci 10 1985 141 146
19. A.B. Newman, E.M. Simonsick, and B.L. Naydeck et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability JAMA 295 2006 2018 2026
20. J.E. Ware Jr., and B. Gandek Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project J Clin Epidemiol 51 1998 903 912
21. D.R. Taaffe, D.A. Galvão, J.E. Sharman, and J.S. Coombes Reduced central blood pressure in older adults following progressive resistance training J Hum Hypertens 21 2007 96 98
22. E.M. Simonsick, E. Fan, and J.L. Fleg Estimating cardiorespiratory fitness in well-functioning older adults: treadmill validation of the long distance corridor walk J Am Geriatr Soc 54 2006 127 132
23. S.M. Alibhai, H. Breunis, and N. Timilshina et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer J Clin Oncol 28 2010 5038 5045
24. D.A. Galvão, K. Nosaka, and D.R. Taaffe et al. Resistance training and reduction of treatment side effects in prostate cancer patients Med Sci Sports Exerc 38 2006 2045 2052
25. J.E. Ware Jr., M. Kosinski, J.B. Bjorner, D.M. Turner-Bowker, B. Gandek, and M.E. Maruish User's manual for the SF-36v2 Health Survey ed. 2. 2008 QualityMetric Incorporated Lincoln, RI
26. J.E. Ware Jr., M.S. Bayliss, W.H. Rogers, M. Kosinski, and A.R. Tarlov Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study JAMA 276 1996 1039 1047
27. N.A. Spry, D.R. Taaffe, and P.J. England et al. Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study Prostate Cancer Prostatic Dis 16 2013 67 72
28. F. Taylor, M.D. Huffman, and A.F. Macedo et al. Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 2013 CD004816
29. W. Demark-Wahnefried, N.M. Aziz, J.H. Rowland, and B.M. Pinto Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer J Clin Oncol 23 2005 5814 5830